wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38737924-1586605D-9A80-48A0-A67B-200C97A7A3B3
Q38737924-1586605D-9A80-48A0-A67B-200C97A7A3B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38737924-1586605D-9A80-48A0-A67B-200C97A7A3B3
Cancer Immunotherapy: Whence and Whither.
P2860
Q38737924-1586605D-9A80-48A0-A67B-200C97A7A3B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38737924-1586605D-9A80-48A0-A67B-200C97A7A3B3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fd2a1a255a02ab60e4006aac24b4e5d4a1d6b5fe
P2860
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.